1. Structural neuroimaging biomarkers for obsessive-compulsive disorder in the ENIGMA-OCD consortium: medication matters
- Author
-
Jonathan P. Shock, Erika L. Nurmi, Francesco Benedetti, Gianfranco Spalletta, Anthony C. James, Damiaan Denys, Jose C. Pariente, Ignacio Martínez-Zalacaín, Yanni Liu, Paulo Marques, Joseph O'Neill, Ganesan Venkatasubramanian, Benjamin A. Ely, Noam Soreni, Tobias U. Hauser, Michael C. Stevens, Masaru Kuno, Kate D. Fitzgerald, Je-Yeon Yun, Stephanie H. Ameis, John Piacentini, Yuki Sakai, Kang Ik K. Cho, Kathrin Koch, Luciano Minuzzi, Fabrizio Piras, Hao Hu, Chaim Huyser, Philip R. Szeszko, Gerd Kvale, Zhen Wang, Luke Taylor, Jean Paul Fouche, Marcelo Q. Hoexter, Francesca Assogna, Odile A. van den Heuvel, Rachel Marsh, Carles Soriano-Mas, Alan Anticevic, David Mataix-Cols, Eiji Shimizu, Fern Jaspers-Fayer, Rajat M. Thomas, Yoshinari Abe, Pedro Moreira, Norbert Kathmann, Astrid Morer, Rosa Calvo, Guido van Wingen, João Ricardo Sato, Egill A. Fridgeirsson, Chris Perriello, Janardhanan C. Narayanaswamy, Anushree Bose, Pedro Morgado, Oana G. Rus-Oswald, Akiko Nakagawa, Silvia Brem, Luisa Lazaro, Dan J. Stein, Paul D. Arnold, Yoshiyuki Hirano, Premika S.W. Boedhoe, Emily R. Stern, Irene Bollettini, Sara Dallaspezia, Lianne Schmaal, Federica Piras, Willem B Bruin, José M. Menchón, Jan K. Buitelaar, Christian Kaufmann, Christine Lochner, Yuqi Cheng, Brian P. Brennan, H. Blair Simpson, David F. Tolin, Daan van Rooij, Pino Alonso, Iliyan Ivanov, S. Evelyn Stewart, Paul M. Thompson, Takashi Nakamae, Deniz A. Gürsel, Paul Zhutovsky, Jan C. Beucke, Jamie D. Feusner, Patricia Gruner, Tomohiro Nakao, Y.C. Janardhan Reddy, Jun Soo Kwon, Graduate School, ANS - Compulsivity, Impulsivity & Attention, APH - Global Health, APH - Mental Health, Adult Psychiatry, Child Psychiatry, Bruin, Willem B., Taylor, Luke, Thomas, Rajat M., P Shock, Jonathan, Zhutovsky, Paul, Abe, Yoshinari, Alonso, Pino, Ameis, Stephanie H., Anticevic, Alan, Arnold, Paul D., Assogna, Francesca, Benedetti, Francesco, Beucke, Jan C., Boedhoe, Premika S. W., Bollettini, Irene, Bose, Anushree, Brem, Silvia, Brennan, Brian P., K Buitelaar, Jan, Calvo, Rosa, Cheng, Yuqi, Cho, Kang Ik K., Dallaspezia, Sara, Denys, Damiaan, Ely, Benjamin A., Feusner, Jamie D., Fitzgerald, Kate D., Fouche, Jean-Paul, Fridgeirsson, Egill A., Gruner, Patricia, Gürsel, Deniz A., Hauser, Tobias U., Hirano, Yoshiyuki, Hoexter, Marcelo Q., Hu, Hao, Huyser, Chaim, Ivanov, Iliyan, James, Anthony, Jaspers-Fayer, Fern, Kathmann, Norbert, Kaufmann, Christian, Koch, Kathrin, Kuno, Masaru, Kvale, Gerd, Soo Kwon, Jun, Liu, Yanni, Lochner, Christine, Lázaro, Luisa, Marques, Paulo, Marsh, Rachel, Martínez-Zalacaín, Ignacio, Mataix-Cols, David, Menchón, José M., Minuzzi, Luciano, Moreira, Pedro S., Morer, Astrid, Morgado, Pedro, Nakagawa, Akiko, Nakamae, Takashi, Nakao, Tomohiro, Narayanaswamy, Janardhanan C., Nurmi, Erika L., O’Neill, Joseph, Pariente, Jose C., Perriello, Chri, Piacentini, John, Piras, Fabrizio, Piras, Federica, Janardhan Reddy, Y. C., Rus-Oswald, Oana G., Sakai, Yuki, Sato, João R., Schmaal, Lianne, Shimizu, Eiji, Blair Simpson, H., Soreni, Noam, Soriano-Mas, Carle, Spalletta, Gianfranco, Stern, Emily R., Stevens, Michael C., Evelyn Stewart, S., Szeszko, Philip R., Tolin, David F., Venkatasubramanian, Ganesan, Wang, Zhen, Yun, Je-Yeon, van Rooij, Daan, Consortium, ENIGMA-OCD, Thompson, Paul M., van den Heuvel, Odile A., Stein, Dan J., van Wingen, Guido A., Netherlands Institute for Neuroscience (NIN), ENIGMA-OCD Working Group, Anatomy and neurosciences, Amsterdam Neuroscience - Compulsivity, Impulsivity & Attention, and Psychiatry
- Subjects
Obsessive-Compulsive Disorder ,Multivariate analysis ,Disease ,Neuroimaging biomarkers ,0302 clinical medicine ,Obsessive-compulsive disorder ,Medicine ,Psychology ,Prefrontal cortex ,screening and diagnosis ,medicine.diagnostic_test ,Biochemical markers ,Brain ,Serious Mental Illness ,Magnetic Resonance Imaging ,3. Good health ,Psychiatry and Mental health ,Detection ,Mental Health ,Marcadors bioquímics ,Public Health and Health Services ,Biomedical Imaging ,Clinical psychology ,medicine.drug ,medicine.medical_specialty ,Clinical Sciences ,MEDLINE ,Neuroimaging ,Article ,lcsh:RC321-571 ,Cellular and Molecular Neuroscience ,03 medical and health sciences ,Obsessive compulsive ,Clinical Research ,Internal medicine ,Medical imaging ,Diagnostic biomarker ,Humans ,Clinical significance ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,Biological Psychiatry ,Fluoxetine ,business.industry ,Neurosi obsessiva ,Neurosciences ,Magnetic resonance imaging ,Diagnostic markers ,030227 psychiatry ,Brain Disorders ,4.1 Discovery and preclinical testing of markers and technologies ,Obsessive compulsive disorder ,ENIGMA-OCD Working Group ,business ,030217 neurology & neurosurgery ,Biomarkers ,Neuroscience - Abstract
ObjectiveNo diagnostic biomarkers are available for obsessive-compulsive disorder (OCD). Magnetic resonance imaging (MRI) studies have provided evidence for structural abnormalities in distinct brain regions, but effect sizes are small and have limited clinical relevance. To investigate whether individual patients can be distinguished from healthy controls, we performed multivariate analysis of structural neuroimaging data from the ENIGMA-OCD consortium.MethodWe included 46 data sets with neuroimaging and clinical data from adult (≥18 years) and pediatric (1images from 2,304 OCD patients and 2,068 healthy controls were analyzed using standardized processing to extract regional measures of cortical thickness, surface area and subcortical volume. Machine learning classification performance was tested using cross-validation, and possible effects of clinical variables were investigated by stratification.ResultsClassification performance for OCD versus controls using the complete sample with different classifiers and cross-validation strategies was poor (AUC—0.57 (standard deviation (SD)=0.02;Pcorr=0.19) to 0.62 (SD=0.03;Pcorrcorr>.99) to 0.54 (SD=0.08;Pcorr>.99)). In contrast, good classification performance (>0.8 AUC) was achieved within subgroups of patients split according to their medication status.ConclusionsParcellated structural MRI data do not enable good distinction between patients with OCD and controls. However, classifying subgroups of patients based on medication status enables good identification at the individual subject level. This underlines the need for longitudinal studies on the short- and long-term effects of medication on brain structure.
- Published
- 2020
- Full Text
- View/download PDF